Role of IL-6/STAT3 Axis in Resistance to Cisplatin in Gastric Cancers
Simona Laurino(Centro di Riferimento Oncologico della Basilicata), Tiziana Notarangelo(Centro di Riferimento Oncologico della Basilicata)
Cited by 23
Related Papers
Dual EGFR and BRAF blockade overcomes resistance to vemurafenib in BRAF mutated thyroid carcinoma cells
|Cancer Cell International|2017|36
Cationic Channel TRPV2 Overexpression Promotes Resistance to Cisplatin-Induced Apoptosis in Gastric Cancer Cells
|Frontiers in Pharmacology|2021|16